Julie Gralow, MD, was named Woman Oncologist of the Year by Women Leaders in Oncology.
The Latest
U.S. News & World Report evaluated 899 hospitals across the country and ranked them for treating leukemia, lymphoma, melanoma, breast, kidney, colon, prostate, pancreatic, head and neck, orthopedic, uterine and ovarian cancers.
Even though a majority of breast cancer cases are diagnosed without a lump that can be detected, less than half recognize other symptoms often associated with it, according to new research from the Ohio State University Comprehensive Cancer Center.
Mass General Brigham President and CEO Anne Klibanski, MD, shared a muted reaction to longtime affiliate Dana-Farber Cancer Institute's decision to partner with another Boston health system for cancer care in a recent op-ed with the Boston Globe.
Results from a pilot study led by New York City-based Memorial Sloan Kettering Cancer Center suggest that a single blood test may be able to detect the presence of 50 different cancer types, according to an Oct. 13 news release.
More than 1.9 million people are estimated to develop new cancer cases and more than 609,000 are estimated to die of cancer in 2023, according to estimates compiled by the American Cancer Society.
HCA Healthcare's Johnston-Willis Hospital in Richmond, Va., is the first in the nation to provide a new treatment for patients with brain metastases from lung cancer.
An emerging artificial intelligence-powered tool, known as Sturgeon, successfully diagnosed 45 out of 50 frozen brain tumor samples in a matter of just 40 minutes. In living patients, the tool was capable of accurately diagnosing 18 out of 25 cases,…
Detroit-based Karmanos Cancer Institute launched a questionnaire that identifies high-risk cancer patients with a few extra questions.
The recurrence of prostate cancer can now be detected 14.8 months sooner than existing clinical practices with new technology developed by a professor at Purdue University in West Lafayette, Ind.